Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans

Brain, Behavior, and Immunity

Volumn 52, Issue , 2016, Pages 81-87

  Banks, William A ^a,b   Dohi, Kenji ^a,b,c   Hansen, Kim ^a,b   Thompson, Hilaire J ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Blood brain barrier; G CSF; Neuroinflammation; Traumatic brain injury

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER; CYTOKINE;

ACUTE TRAUMATIC BRAIN INJURY; ADULT; AGE DISTRIBUTION; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EMERGENCY WARD; HUMAN; MIDDLE AGED; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY; VERY ELDERLY; YOUNG ADULT; AGE; ANIMAL; BLOOD; BLOOD BRAIN BARRIER; BRAIN; C57BL MOUSE; DISEASE MODEL; FEMALE; MALE; METABOLISM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN INJURIES, TRAUMATIC; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PILOT PROJECTS; YOUNG ADULT;

EID: 84953360826     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.10.002     Document Type: Article

References (31)

1. Acosta S.A., Tajiri N., Shinozuka K., Ishikawa H., Sanberg P.R., Sanchez-Ramos J., Song S., Kaneko Y., Borlongan C.V. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One 2014, 9:e90953.
2. Baker S.P., O'Neill B. The injury severity score: an update. J. Trauma 1976, 16:882-885.
3. Baker S.P., O'Neill B., Haddon W., Long W.B. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 1974, 14:187-196.
4. Banks W.A. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav. Immun. 2015, 44:1-8.
5. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Pers. Soc. Psychol. 1986, 51:1173-1182.
6. Bendall L.J., Bradstock K.F. G-CSF: from granulocpoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014, 25:355-367.
7. Blatteis C.M. Role of the OVLT in the febrile response to circulating pyrogens. Circumventricular Organs and Brain Fluid Environment 1992, 409-412. Elsevier, Amsterdam. A. Ermisch, R. Landgraf, H.J. Ruhle (Eds.).
8. Chen G., Reichlin S. Clearance of [125 I]-tumor necrosis factor-alpha from the brain into the blood after intracerebroventricular injection into rats. Neuroimmunomodulation 1998, 5:261-269.
9. Clausen F., Hanell A., Bjork M., Hillered L., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1 beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury. Eur. J. Neurosci. 2009, 30:385-396.
10. Dohi K., Kraemer B.C., Erickson M.A., McMillian P.J., Kovac A., Flachbartova Z., Hansen K.M., Shah G.N., Sheibani N., Salameh T., Banks W.A. Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS One 2014, 24(29):e108034.
11. Frank T., Klinker F., Falkenburger B.H., Laage R., Luhder F., Goricke B., Schneider A., Neurath H., Desel H., Liebetanz D., Bahr M., Weishaupt J.H. Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. Brain 2012, 135:1914-1925.
12. Ghorbani M., Moallem S., Abnous K., Tabatabaee Yazdi S.A., Movassaghi A.R., Azizzadeh M., Mohamadpour A.H. The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats. Drug Chem. Toxicol. 2013, 36:102-108.
13. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., Watkins L.R. Interleukin-1 beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 1999, 19:2799-2806.
14. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine responses to human tramatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2011, 31:658-670.
15. Hong Y., Deng C., Zhang J., Zhu J., Li Q. Neuroprotective effect of granulocyte colony-stimulating factor in a focal cerebral ischemia rat model with hyperlipidemia. J. Huazhong Univ. Sci. Technol. Med. Sci. 2012, 32:872-878.
16. Ley E.J., Clond M.A., Singer M.B., Shouhead D., Salim A. IL6 deficiency affects function after traumatic brain injury. J. Surg. Res. 2011, 170:253-256.
17. MacKenzie E.J., Rivara F.P., Jurkovich G.J., Nathens A.B., Frey K.P., Egleston B.L., Salkever D.S., Scharfstein D.O. A national evalualtion of the effect of trauma-center care on mortality. N. Engl. J. Med. 2006, 356:366-378.
18. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., Stocker R., Trentz O., Kossmann T. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry 1997, 2:133-136.
19. Quan N., Banks W.A. Brain-immune communication pathways. Brain Behav. Immun. 2007, 21:727-735.
20. Romero L.I., Kakucska I., Lechan R.M., Reichlin S. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1 β in rats. Am. J. Physiol. 1996, 270:R518-R524.
21. Sasser S.M., Hunt R.C., Faul M., Sugerman D., Pearson W.S., Dulski T., Wald M.M., Jurkovich G.J., Newgard C.D., Lerner E.B., Cooper A., Wang S.C., Henry M.C., Salomone J.P., Galli R.L. Centers for disease control and prevention guidelines for field triage of injured patients: recommendation of the national expert panel of field triage, 2011. MMWR Recomm. Rep. 2012, 61:1-20.
22. Sayer N.A. Traumatic brain injury and its neuropsychiatric sequelae in war veterans. Annu. Rev. Med. 2012, 63:405-419.
23. Sobrino T., Arias S., Rodriguez-Gonzalez R., Brea D., Silva Y., de la Ossa N.P., Agulla J., Blanco M., Pumar J.M., Serena J., Davalos A., Castillo J. High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 2009, 29:1968-1974.
24. Sun D., Bullock M.R., McGinn M.J., Zhou Z., Altememi N., Hagood S., Hamm R., Colello R.J. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp. Neurol. 2009, 216:56-65.
25. Sun D., Bullock M.R., Altememi N., Zhou Z., Hagood S., Rolfe A., McGinn M.J., Hamm R., Colello R.J. The effect of epidermal growth factor in the injured brain after trauma in rats. J. Neurotrauma 2010, 27:923-938.
26. Sun B.-L., He M.-Q., Han X.-Y., Sun J.-Y., Yang M.-F., Yuan H., Fan C.-D., Zhang S., Mao L.-L., Li D.-W., Zhang Z.-Y., Zheng C.-B., Yang X.-Y., Li Y.V., Stetler R.A., Chen J., Zhang F. Intranasal delivery of granulocyte colony-stimulating factor enhances its neuroprotective effects against ischemic brain injury in rats. Mol. Neurobiol. 2014, epub.
27. The Abbreviated Injury Scale: 2008 update, 2008. Association for the Advancement of Automotive Medicine, Des Plaines, IL.
28. Yildiz R., Coskun U., Buyukberber S., Sancak B., Kaya A.O., Gulbahar O., Benekli M. Serum granulocyte colony-stimulating factor levels in gliomas. J. BUON 2011, 16:138-141.
29. Yu S.C., Kuo C.L., Huang C.S., Chang C.S., Wu S.L., Su S.L., Liu C.S. Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke. Biomarkers 2012, 17:319-324.
30. Zhao L.R., Navalitloha Y., Singhal S., Mehta J., Piao C.S., Guo W.P., Kessler J.A., Groothuis D.R. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp. Neurol. 2007, 204:569-573.
31. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.